Bioactive neolignans and lignans from the bark of Machilus robusta.

Yanru Li,Wei Cheng,Chenggen Zhu,Chunsuo Yao,Liang Xiong,Ye Tian,Sujuan Wang,Sheng Lin,Jinfeng Hu,Yongchun Yang,Ying Guo,Ying Yang,Yan Li,Yuhe Yuan,Naihong Chen,Jiangong Shi
DOI: https://doi.org/10.1021/np2001896
IF: 5.1
2011-01-01
Journal of Natural Products
Abstract:Sixteen new neolignans and lignans (1-16), together with 12 known analogues, have been isolated from an ethanol extract of the bark of Machilus robusta. Compounds 1 and 2 showed activity against HIV-I replication in vitro, with IC(50) values of 2.52 and 2.01 mu M, respectively. At 10 mu M, 6, 8, and 9 reduced DL-galactosamine-induced hepatocyte (WB-F344 cells) damage, and 9 could additionally attenuate rotenone-induced PC12 cell damage. The known compounds (-)-pinoresinol (17) and (+)-lyoniresinol (18) were active against serum deprivation induced PC12 cell damage.
What problem does this paper attempt to address?